Therefore, genetic, epigenetic, and non-genetic (e.g., tamoxifen or fulvestrant, ESR1 targeting drugs) factors that affect ESR1 function and/or expression may contribute significantly to the liver transcriptome, drug metabolism, and liver diseases. Here, ESR1 is linked to liver disorder.